Antibiotics - Cyclic lipopeptides: Nursing pharmacology

Antibiotics - Cyclic lipopeptides: Nursing pharmacology

SHRAVAM

SHRAVAM

Gastrointestinal system anatomy and physiology
Fractures: Nursing process (ADPIE)
Anaphylaxis: Nursing process (ADPIE)
Lyme disease: Nursing process (ADPIE)
Vaccines: Nursing pharmacology
Immunoglobulins: Nursing pharmacology
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Appendicitis: Nursing process (ADPIE)
Celiac disease: Nursing process (ADPIE)
Cirrhosis: Nursing process (ADPIE)
Gastroesophageal reflux disease (GERD): Nursing process (ADPIE)
Hiatal hernia: Nursing process (ADPIE)
Pancreatitis: Nursing process (ADPIE)
Peptic ulcer disease (PUD): Nursing process (ADPIE)
Antacids: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Weight loss medications: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gallstone-dissolving agents: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Histamine H2 antagonists: Nursing pharmacology
Proton pump inhibitors (PPIs): Nursing pharmacology
Treatment for Helicobacter pylori: Nursing pharmacology
Diuretics - Osmotic and carbonic anhydrase inhibitors: Nursing pharmacology
Cholinergic therapy (GU): Nursing pharmacology
Diabetes insipidus: Nursing process (ADPIE)
Diabetes mellitus (DM): Nursing process (ADPIE)
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hyperosmolar hyperglycemic state (HHS): Nursing process (ADPIE)
Hyperthyroidism: Nursing process (ADPIE)
Hypothyroidism: Nursing process (ADPIE)
Syndrome of inappropriate antidiuretic hormone (SIADH): Nursing process (ADPIE)
Medications for antidiuretic hormone (ADH) disorders: Nursing pharmacology
Medications for thyroid disorders: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Epistaxis: Nursing process (ADPIE)
Eye injury: Nursing process (ADPIE)
Glaucoma: Nursing process (ADPIE)
Tonsillitis: Nursing process (ADPIE)
Antiglaucoma medications: Nursing pharmacology
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Acute compartment syndrome: Nursing process (ADPIE)
Gout: Nursing process (ADPIE)
Musculoskeletal injuries: Nursing process (ADPIE)
Rheumatoid arthritis (RA): Nursing process (ADPIE)
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Analgesics: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Medications for Alzheimer disease: Nursing pharmacology
Skeletal muscle relaxants: Nursing pharmacology
Meningitis: Nursing process (ADPIE)
Parkinson disease: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Trigeminal neuralgia: Nursing process (ADPIE)
Breast cancer: Nursing process (ADPIE)
Tumor lysis syndrome (TLS): Nursing Process (ADPIE)
Plant extracts for chemotherapy: Nursing pharmacology
Peripheral arterial disease (PAD): Nursing process (ADPIE)
Peripheral venous disease (PVD): Nursing process (ADPIE)
Chickenpox (Varicella): Nursing process (ADPIE)
Conjunctivitis: Nursing process (ADPIE)
Hydrocephalus: Nursing process (ADPIE)
Poisoning: Nursing process (ADPIE)
Pyloric stenosis: Nursing process (ADPIE)
Reye syndrome: Nursing process (ADPIE)
Bronchiolitis and respiratory syncytial virus (RSV): Nursing process (ADPIE)
Pharmacokinetics - Elimination: Nursing pharmacology
Anthelmintics: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antibiotics - Metronidazole: Nursing pharmacology
Antibiotics - Oxazolidinones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Polymyxins: Nursing pharmacology
Antibiotics - Cyclic lipopeptides: Nursing pharmacology
Antiprotozoals: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antibiotics - Glycopeptides: Nursing pharmacology
Antimalarials: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Lincosamides: Nursing pharmacology
Antibiotics - Antimycobacterials: Nursing pharmacology
Angiotensin II receptor blockers (ARBs): Nursing pharmacology
Angiotensin-converting enzyme (ACE) inhibitors: Nursing pharmacology
Beta-adrenergic blockers: Nursing pharmacology
Calcium-channel blockers: Nursing pharmacology
Cardiac glycosides: Nursing pharmacology
Direct-acting vasodilators: Nursing pharmacology

Notes

ANTIBIOTICS: CYCLIC LIPOPEPTIDES
DRUG NAME
daptomycin (Cubicin, Cubicin RF)
CLASS
Cyclic lipopeptide antibiotic
MECHANISM OF ACTION
Binds to and perforate bacterial membrane → rapid depolarization → DNA, RNA, and protein synthesis inhibition → bacterial cell death
INDICATIONS
  • Complicated skin infections caused by gram-negative bacteria
  • Bacteremia caused by Staphylococcus aureus
  • Infective endocarditis caused by MRSA
ROUTE(S) OF ADMINISTRATION
  • IV
  • Intrathecal
SIDE EFFECTS
  • Headache, dizziness, insomnia
  • Hypo- or hypertension
  • Abdominal pain, nausea, vomiting, diarrhea, Clostridioides difficile infection (CDI)
  • Pain or burning with urination
  • Skin rash, itching, pallor
  • Peripheral neuropathy → numbness and tingling
  • Eosinophilic pneumonia
  • Nephrotoxicity
  • Anemia
  • Rhabdomyolysis
  • Hypersensitivity reactions
CONTRAINDICATIONS AND CAUTIONS
  • Pregnancy and breastfeeding
  • Children and elderly clients
  • Eosinophilic pneumonia
  • Gastrointestinal, renal, or muscular disease
  • Combination with tobramycin, warfarin, and statins
NURSING CONSIDERATIONS for
ANTIBIOTICS: CYCLIC LIPOPEPTIDES
ASSESSMENT AND MONITORING
Assessment and monitoring: daptomycin IV
  • Assess
    • Weight
    • Vital signs
    • Wound: degree of pain, warmth, redness, swelling, type of exudate
    • Laboratory test results: CBC, liver and renal function tests, ESR, CPK, blood culture and wound culture and sensitivity results; urinalysis
  • Confirm the correct calculation of medication to be administered in mg/kg
  • Monitor
    • Development of side effects
    • Laboratory test results
    • Intake and output
    • Therapeutic response of decreased inflammation and infection
CLIENT EDUCATION
  • Purpose of medication: kill the bacteria causing their infection; decrease pain and discomfort
  • Administered once daily IV
  • Symptoms of side effects to report
    • Myopathy or rhabdomyolysis: muscle aches, pain, or weakness
    • CDI: cramping, diarrhea, bloody stool
    • Peripheral neuropathy: numbness or tingling of their extremities
    • Eosinophilic pneumonia: cough, shortness of breath
Author: Stefan Stoisavljevic, MD
Illustrator: Robyn Hughes, MScBMC

Transcript

Watch video only

Cyclic lipopeptides are a new class of antibiotics used to treat complicated infections caused by gram-positive bacteria like Staphylococcus epidermidis, Staphylococcus haemolyticus, and Staphylococcus aureus, especially the methicillin-resistant type called MRSA, as well as Streptococcus agalactiae, Streptococcus pyogenes, and Enterococcus faecalis.

It is also used in bacteremia caused by Staphylococcus aureus, and infective endocarditis caused by MRSA.

Currently, there is only one approved medication in this class, called daptomycin, which is given intravenously or intrathecally.

Once administered, it works by binding to the bacterial membrane and perforating it, creating holes that leak ions, causing rapid depolarization.

This ultimately leads to inhibition of bacterial DNA, RNA, and protein synthesis, which in turn results in bacterial cell death.

Common side effects of daptomycin include headache, dizziness, insomnia, and hypo- or hypertension.

Clients might also experience gastrointestinal side effects, such as abdominal pain, nausea, vomiting, and diarrhea.

In addition, daptomycin may disrupt the healthy intestinal flora, which can allow certain bacteria like Clostridioides difficile to survive and overgrow within the gastrointestinal tract, rarely but potentially leading to Clostridioides difficile infection or CDI for short.

Other side effects include pain or burning with urination, as well as skin manifestations like rash, itching, and pallor, while some clients may also experience numbness and tingling from peripheral neuropathy.

Other serious side effects include eosinophilic pneumonia, nephrotoxicity, anemia, myopathy and rhabdomyolysis with or without renal failure, and hypersensitivity reactions like angioedema or anaphylaxis.

Now, daptomycin should be used with caution during pregnancy and breastfeeding, as well as in children and elderly clients.

Precaution should be taken in clients with eosinophilic pneumonia, as well as in those with gastrointestinal, renal, or muscular disease.

Sources

  1. "Focus on Nursing Pharmacology" LWW (2019)
  2. "Pharmacology" Elsevier Health Sciences (2014)
  3. "Mosby's 2021 Nursing Drug Reference" Mosby (2020)